These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8157036)

  • 41. Fluvastatin administration at bedtime versus with the evening meal: a multicenter comparison of bioavailability, safety, and efficacy.
    Dujovne CA; Davidson MH
    Am J Med; 1994 Jun; 96(6A):37S-40S. PubMed ID: 8017465
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients.
    Sprecher DL; Abrams J; Allen JW; Keane WF; Chrysant SG; Ginsberg H; Fischer JJ; Johnson BF; Theroux P; Jokubaitis L
    Ann Intern Med; 1994 Apr; 120(7):537-43. PubMed ID: 8093139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluvastatin lowers atherogenic dense low-density lipoproteins in postmenopausal women with the atherogenic lipoprotein phenotype.
    März W; Scharnagl H; Abletshauser C; Hoffmann MM; Berg A; Keul J; Wieland H; Baumstark MW
    Circulation; 2001 Apr; 103(15):1942-8. PubMed ID: 11306521
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and tolerability of fluvastatin with concomitant use of antihypertensive agents. An analysis of a clinical trial database.
    Peters TK; Jewitt-Harris J; Mehra M; Muratti EN
    Am J Hypertens; 1993 Nov; 6(11 Pt 2):346S-352S. PubMed ID: 7905274
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flow cytometric assessment of effects of fluvastatin on low-density lipoprotein receptor activity in stimulated T-lymphocytes from patients with heterozygous familial hypercholesterolemia.
    Raungaard B; Brorholt-Petersen JU; Jensen HK; Faergeman O
    J Clin Pharmacol; 2000 Apr; 40(4):421-9. PubMed ID: 10761170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine.
    Goldberg RB; Roth D
    Am J Cardiol; 1995 Jul; 76(2):107A-109A. PubMed ID: 7604782
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
    Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of fluvastatin slow-release (XL 80 mg) versus simvastatin (20 mg) on the lipid triad in patients with type 2 diabetes.
    Bevilacqua M; Righini V; Barrella M; Vago T; Chebat E; Dominguez LJ
    Adv Ther; 2005; 22(6):527-42. PubMed ID: 16510370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination therapy with fluvastatin and niacin in hypercholesterolemia: a preliminary report on safety.
    Jacobson TA; Amorosa LF
    Am J Cardiol; 1994 May; 73(14):25D-29D. PubMed ID: 8198020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor fluvastatin in hyperlipidemic patients treated with probucol.
    Sasaki S; Nakagawa M; Nakata T; Endo N; Miyao K; Kitamura K; Fukuyama M; Kitani T; Yamada C
    Cardiology; 1997; 88(2):160-5. PubMed ID: 9096917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of fluvastatin in hypertensive patients. An analysis of a clinical trial database.
    Peters TK; Mehra M; Muratti EN
    Am J Hypertens; 1993 Nov; 6(11 Pt 2):340S-345S. PubMed ID: 8297542
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Time-dependent lipid response on fluvastatin therapy of patients with hypercholesterolemia sensitive to apoE phenotype.
    Dergunov AD; Perova NV; Visvikis S; Siest G
    Vascul Pharmacol; 2003 Dec; 40(5):237-45. PubMed ID: 15259790
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of fluvastatin in children and adolescents with heterozygous familial hypercholesterolaemia.
    van der Graaf A; Nierman MC; Firth JC; Wolmarans KH; Marais AD; de Groot E
    Acta Paediatr; 2006 Nov; 95(11):1461-6. PubMed ID: 17062478
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elderly patients with hypercholesterolaemia: a double-blind study of the efficacy, safety and tolerability of fluvastatin.
    Lye M; Valacio R; Reckless JP; Ghosh AK; Findlay IN; Ghosh MK; Passmore AP; Fulcher RA
    Coron Artery Dis; 1998; 9(9):583-90. PubMed ID: 9861520
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT study). Fluvastatin Alone and in Combination Treatment.
    Cortellaro M; Cofrancesco E; Boschetti C; Cortellaro F; Mancini M; Mariani M; Paoletti R
    Thromb Haemost; 2000 Apr; 83(4):549-53. PubMed ID: 10780315
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of fluvastatin 40 mg every other day versus 20 mg every day in patients with hypercholesterolemia.
    Rindone JP; Hiller D; Arriola G
    Pharmacotherapy; 1998; 18(4):836-9. PubMed ID: 9692657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolaemia.
    Plosker GL; Wagstaff AJ
    Drugs; 1996 Mar; 51(3):433-59. PubMed ID: 8882381
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term treatment of hypercholesterolemia with fluvastatin: a 52-week multicenter safety and efficacy study. French-Dutch Fluvastatin Study Group.
    Banga JD; Jacotot B; Pfister P; Mehra M
    Am J Med; 1994 Jun; 96(6A):87S-93S. PubMed ID: 8017473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency.
    Samuelsson O; Attman PO; Knight-Gibson C; Mulec H; Weiss L; Alaupovic P
    Am J Kidney Dis; 2002 Jan; 39(1):67-75. PubMed ID: 11774104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of fluvastatin on hyperlipidemia after renal transplantation.
    Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
    Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.